Yao TJ - Search Results

1

Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.

Yao TJ, Meyers M, Livingston PO, Houghton AN, Chapman PB. Yao TJ, et al. Clin Cancer Res. 1999 Jan;5(1):77-81. Clin Cancer Res. 1999. PMID: 9918205 Clinical Trial.

2

A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma.

Minasian LM, Yao TJ, Steffens TA, Scheinberg DA, Williams L, Riedel E, Houghton AN, Chapman PB. Minasian LM, et al. Among authors: yao tj. Cancer. 1995 May 1;75(9):2251-7. doi: 10.1002/1097-0142(19950501)75:9<2251::aid-cncr2820750910>3.0.co;2-f. Cancer. 1995. PMID: 7536122 Clinical Trial.

3

Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies.

Livingston P, Zhang S, Adluri S, Yao TJ, Graeber L, Ragupathi G, Helling F, Fleisher M. Livingston P, et al. Among authors: yao tj. Cancer Immunol Immunother. 1997 Jan;43(6):324-30. doi: 10.1007/s002620050340. Cancer Immunol Immunother. 1997. PMID: 9067403 Free PMC article.

4

Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.

McCaffery M, Yao TJ, Williams L, Livingston PO, Houghton AN, Chapman PB. McCaffery M, et al. Among authors: yao tj. Clin Cancer Res. 1996 Apr;2(4):679-86. Clin Cancer Res. 1996. PMID: 9816218 Clinical Trial.

5

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao TJ, Panageas K, Moynahan M, Houghton A, Norton L, Livingston PO. Gilewski T, et al. Among authors: yao tj. Clin Cancer Res. 2000 May;6(5):1693-701. Clin Cancer Res. 2000. PMID: 10815887 Clinical Trial.

6

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.

Helling F, Zhang S, Shang A, Adluri S, Calves M, Koganty R, Longenecker BM, Yao TJ, Oettgen HF, Livingston PO. Helling F, et al. Among authors: yao tj. Cancer Res. 1995 Jul 1;55(13):2783-8. Cancer Res. 1995. PMID: 7796403 Clinical Trial.

7

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma.

Livingston PO, Adluri S, Helling F, Yao TJ, Kensil CR, Newman MJ, Marciani D. Livingston PO, et al. Among authors: yao tj. Vaccine. 1994 Nov;12(14):1275-80. doi: 10.1016/s0264-410x(94)80052-2. Vaccine. 1994. PMID: 7856291 Clinical Trial.

8

Optimal sample size for a series of pilot trials of new agents.

Yao TJ, Begg CB, Livingston PO. Yao TJ, et al. Biometrics. 1996 Sep;52(3):992-1001. Biometrics. 1996. PMID: 8805764

9

Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia.

Jurcic JG, DeBlasio T, Dumont L, Yao TJ, Scheinberg DA. Jurcic JG, et al. Among authors: yao tj. Clin Cancer Res. 2000 Feb;6(2):372-80. Clin Cancer Res. 2000. PMID: 10690513 Clinical Trial.

10

Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.

D'Andrea G, Fennelly D, Norton L, Baselga J, Gilewski T, Hudis C, Moynahan ME, Raptis G, Sklarin N, Surbone A, Theodoulou M, Templeton MA, Yao TJ, Seidman AD. D'Andrea G, et al. Among authors: yao tj. Clin Cancer Res. 1999 Feb;5(2):275-9. Clin Cancer Res. 1999. PMID: 10037175 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters